ImmuCell Corp
(NASDAQ:ICCC)
$5.49
0.95[20.93%]
Last update: 9:29AM (Delayed 15-Minutes)
Get Real Time Here
$5.49
0[0.00%]
After-Hours
PerksBuyCompare Brokers
Open4.460Close4.480
Vol / Avg.13.248K / 15.641KMkt Cap42.552M
Day Range4.460 - 4.50052 Wk Range4.260 - 7.840

ImmuCell Stock (NASDAQ:ICCC), Quotes and News Summary

ImmuCell Stock (NASDAQ: ICCC) stock price, news, charts, stock research, profile.

Open4.460Close4.480
Vol / Avg.13.248K / 15.641KMkt Cap42.552M
Day Range4.460 - 4.50052 Wk Range4.260 - 7.840
Lisa Levin - Jul 12, 2023, 8:19AM
Lisa Levin - Jul 12, 2023, 4:06AM
Lisa Levin - Apr 26, 2022, 4:58AM
Shanthi Rexaline - Nov 14, 2021, 9:57AM
Lisa Levin - Aug 25, 2021, 4:50AM
Lisa Levin - Aug 24, 2021, 2:45PM
Lisa Levin - Aug 24, 2021, 12:17PM
Lisa Levin - Aug 24, 2021, 12:10PM
Shanthi Rexaline - Aug 12, 2021, 8:09AM
Shanthi Rexaline - Aug 8, 2021, 10:03AM
Globe Newswire - Nov 13, 2023, 4:05PM
Globe Newswire - Nov 7, 2023, 12:15PM
Globe Newswire - Oct 5, 2023, 4:05PM
Globe Newswire - Aug 29, 2023, 8:00AM
Globe Newswire - Aug 10, 2023, 4:05PM
Globe Newswire - Aug 7, 2023, 12:00PM
Globe Newswire - Jul 11, 2023, 4:05PM
Globe Newswire - Jun 28, 2023, 4:05PM
Globe Newswire - Jun 21, 2023, 4:05PM
Globe Newswire - Jun 15, 2023, 4:05PM
Full archive of press releases available on Benzinga Pro
Seeking Alpha - Nov 14, 2023, 2:36PM
Seeking Alpha - Nov 13, 2023, 4:23PM
InvestorsObserver - Oct 24, 2023, 10:38AM
Seeking Alpha - Aug 11, 2023, 4:48PM
Seeking Alpha - Aug 10, 2023, 4:29PM
Seeking Alpha - Jul 11, 2023, 6:02PM
Seeking Alpha - Jun 28, 2023, 6:14PM
Seeking Alpha - Jun 15, 2023, 5:50PM
InvestorsObserver - May 12, 2023, 1:20PM
Sector: Health Care.Industry: Biotechnology

Earnings

see more
Q4 2023Est.ActualSurprise
EPS
(EXPECTED)
REV
Q3 2023Est.ActualSurprise
EPS-0.120
REV5.397M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
2020-07-13Aegis CapitalNathan WeinsteinInitiates Coverage OnBuyAnnounces-14.00

Related Companies

TickerCompanyChg %Mkt Cap
ICCCImmuCell20.93%42.6M
OCXOncoCyte0%31.4M
GANXGain Therapeutics0.47%34.1M
INTSIntensity Therapeutics30.18%43.7M
COEPCoeptis Therapeutics1.71%40.6M
Q

How do I buy ImmuCell (ICCC) stock?

A

You can purchase shares of ImmuCell (NASDAQ: ICCC) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ImmuCell's (ICCC) competitors?

A

Other companies in ImmuCell’s space includes: OncoCyte (NASDAQ:OCX), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Coeptis Therapeutics (NASDAQ:COEP) and Bolt Biotherapeutics (NASDAQ:BOLT).

Q

What is the target price for ImmuCell (ICCC) stock?

A

The latest price target for ImmuCell (NASDAQ: ICCC) was reported by Aegis Capital on Monday, July 13, 2020. The analyst firm set a price target for 14.00 expecting ICCC to rise to within 12 months (a possible 155.01% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ImmuCell (ICCC)?

A

The stock price for ImmuCell (NASDAQ: ICCC) is $5.49 last updated November 8, 2023 at 2:29 PM UTC.

Q

Does ImmuCell (ICCC) pay a dividend?

A

There is no dividend information for ImmuCell.

Q

When is ImmuCell (NASDAQ:ICCC) reporting earnings?

A

ImmuCell’s Q4 earnings are confirmed for Tuesday, February 20, 2024.

Q

Is ImmuCell (ICCC) going to split?

A

There is no upcoming split for ImmuCell.

Q

What sector and industry does ImmuCell (ICCC) operate in?

A

ImmuCell is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.